← News & Research
Conference

[2026] Participating in NUS Medicine · China Academic Partnership Week

October 26, 2026

[2026] Participating in NUS Medicine · China Academic Partnership Week

Hello! We are Bredis Healthcare.

 We are excited to share that we participated in the NUS Medicine · China Academic Partnership Week 2026, held from October 19 (Mon) to 23 (Fri) at Geneo Bridge+, Nexus Hall, Singapore!

This flagship event, co-hosted by NUS Yong Sloo Lin School of Medicine, Shanghai Jiao Tong University School of Medicine, and Zhejiang University School of Medicine, is one of Asia’s largest academic partnership gatherings in medicine and clinical research. Bringing together professors, clinicians, and researchers to share the latest findings and strengthen inter-institutional collaboration, we joined to introduce our blood-based biomarker analysis technologies and explore opportunities for global research partnerships and business collaboration.

Throughout the event, we showcased our biomarker and multi-omics proteomics panel analysis capabilities utilizing SIMOA and NULISA. A highlight of our participation came on October 21 at the NUS Medicine China Academic Partnership Summit, where our CEO, Hyundoo Hwang, took the stage as a speaker to present on the topic ‘From Discovery to Clinical-Grade Evidence’ — sharing our vision and technology for translating early-stage research findings into clinically validated evidence.

We also held partnering meetings with research teams from leading universities across China and Singapore, as well as potential partner organizations, laying the groundwork for meaningful follow-up discussions on global cohort studies and multi-institutional collaboration.

Bredis Healthcare will continue expanding our global research network and pushing the boundaries of blood-based precision diagnostics. Thank you for your continued interest and support!